Compositional Variations in Calcium Phosphate Cement and Poly(Lactic-Co-Glycolic-Acid) Porogens Do Not Affect the Orthotopic Performance of Calcium Phosphate Cement/Poly(Lactic-Co-Glycolic-Acid) Cements
- PMID: 39473125
- DOI: 10.1002/jbm.a.37827
Compositional Variations in Calcium Phosphate Cement and Poly(Lactic-Co-Glycolic-Acid) Porogens Do Not Affect the Orthotopic Performance of Calcium Phosphate Cement/Poly(Lactic-Co-Glycolic-Acid) Cements
Abstract
Calcium phosphate cement (CPC) has evolved as an appealing bone substitute material, especially since CPCs were combined with poly(lactic-co-glycolic acid) (PLGA) porogens to render the resulting CPC/PLGA composite degradable. In view of the multiple variables of CPC and PLGA used previously, the effect of CPC composition and PLGA porogen morphology (i.e., microspheres versus microparticles) on the biological performance of CPC/PLGA has not yet been investigated. Consequently, we here aimed to evaluate comparatively various CPC/PLGA formulations varying in CPC composition and PLGA porogen morphology on their performance in a rabbit femoral condyle bone defect model. CPCs with a composition of 85 wt% α-TCP, 15 wt% dicalcium phosphate anhydrate (DCPA) and 5 wt% precipitated hydroxyapatite (pHA), or 100 wt% α-TCP were combined with spherical or irregularly shaped PLGA porogens (CPC/PLGA ratio of 60:40 wt% for all formulations). All CPC/PLGA formulations were applied via injection in bone defects, as created in the femoral condyle of rabbits, and retrieved for histological evaluation after 6 and 12 weeks of implantation. Descriptive histology and quantitative histomorphometry (i.e., material degradation and new bone formation) were used for analyses. Descriptively, all CPC/PLGA formulations showed material degradation at the periphery of the cement within 6 weeks of implantation. After 12 weeks, bone formation was observed extending into the defect core, replacing the degraded CPC/PLGA material. Quantitatively, similar material degradation (up to 87%) and new bone formation (up to 28%) values were observed, irrespective of compositional variations of CPC/PLGA formulations. These data prove that neither the CPC compositions nor the PLGA porogen morphologies as used in this work affect the biological performance of CPC/PLGA formulations in a rabbit femoral condyle bone defect model.
Keywords: bone regeneration; calcium phosphate cement; material degradation; orthotopic performance; poly(lactic‐co‐glycolic‐acid).
© 2024 The Author(s). Journal of Biomedical Materials Research Part A published by Wiley Periodicals LLC.
References
-
- J. C. Yeoh and B. A. Taylor, “Osseous Healing in Foot and Ankle Surgery With Autograft, Allograft, and Other Orthobiologics,” Orthopedic Clinics of North America 48, no. 3 (2017): 359–369.
-
- E. Roddy, M. R. DeBaun, A. Daoud‐Gray, Y. P. Yang, and M. J. Gardner, “Treatment of Critical‐Sized Bone Defects: Clinical and Tissue Engineering Perspectives,” European Journal of Orthopaedic Surgery and Traumatology 28, no. 3 (2018): 351–362.
-
- W. Wang and K. W. K. Yeung, “Bone Grafts and Biomaterials Substitutes for Bone Defect Repair: A Review,” Bioactive Materials 2, no. 4 (2017): 224–247.
-
- J. Lu, H. Yu, and C. Chen, “Biological Properties of Calcium Phosphate Biomaterials for Bone Repair: A Review,” RSC Advances 8, no. 4 (2018): 2015–2033.
-
- P. Q. Ruhe, E. L. Hedberg, N. Torio‐Padron, P. H. K. Spauwen, J. Jansen, and A. G. Mikos, “Biocompatibility and Degradation of Poly(DL‐Lactic‐Co‐Glycolic Acid)/Calcium Phosphate Cement Composites,” Journal of Biomedical Materials Research. Part A 74, no. 4 (2005): 533–544.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources